Category Archives: Medicine Wellness Health

Medicine Wellness Health

Maisense Presented Telecardiology System That Can Measure Blood Pressure and Record ECG Simultaneously at ESC Munich

Maisense Presented Telecardiology System That Can Measure Blood Pressure and Record ECG Simultaneously at ESC Munich

Bach Chen, Vice President of business development, Maisense (Source: © Maisense)

Hsinchu, Taiwan Aug 29th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention, today announced the telecardiology system using a portable device „Freescan“ that can measure blood pressure and record ECG simultaneously.

„For most telecardiology systems on the market, they either provide only ECG, or provide both blood pressure and ECG but retrieve them from two independent devices. The more devices there are, the less likely for patients to use all of them regularly.“ said Bach Chen, Vice President of business development, Maisense.

The purpose of Maisense“s telecardiology system is to simplify the measurement procedure for patients. Through the combination of three elements: the Freescan device, the myFreescan App, and the Patient Care web platform, patients can measure blood pressure and ECG with a single device. In addition, doctors are able to monitor patients“ health condition easily through the web-based Patient Care System. Maisense Freescan in combination with the myFreescan App delivers a combined all-in-1 solution utilizing artificial intelligence (AI) for early atrial fibrillation detection (AFib), arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device.

According to World Health Organization (WHO)“s report in May 2018, stroke incidents are globally the second most common cause of death after ischaemic heart disease. Of the 56.9 million deaths worldwide in 2016, almost 6 million died persons died of strokes, this is about 10% of all the accounted deaths. However, up to 80% of strokes may be preventable by monitoring the major risk factors: arterial stiffness, atrial fibrillation (AFib), and hypertension.

The adoption of Maisense“s telecardiology system will enable every user of the solution to assess their risk level of strokes anytime. Therefore then they can take preventive actions to minimize the risk.

Maisense held a session to elaborate telecardiology system at the ESC (European Society of Cardiology) congress in Munich on August 28th.
„I believe that solid researches lead to excellent innovation. Therefore, we continue to push the boundaries on digital health support, and on top of that, we value each opportunity to present our system at conferences or academia“, said Benjamin Chiu, CEO, Maisense.

Maisense is also growing its channel and is actively looking for distributors in the European Union. In Germany, Maisense is excited to have formed a partnership with the well renowned TITAN Commerce and appPeople. TITAN Commerce is a leading distributor for Bio-/Neurofeedback, sportswear technology and wearables based in Germany. appPeople provides worldwide progressive impulses in the field of telemedicine. Freescan is also available in Germany at Mindtec and ME Health CHECK.

Maisense is proud to be a member of the Global Research & Industry Alliance (GLORIA-Semicon) which focuses on future-oriented technology and builds a cooperation platform between universities and the industry. The organization stimulates innovation and introduces Taiwan startup companies to the global market.

About TITAN Commerce
TITAN Commerce“s wide product range includes state-of-the-art biotechnology, wearables and professional Sportswear technologies from various well-known biofeedback, neurofeedback and wearable manufacturers. The goal of TITAN Commerce is to provide end-customer with the most technically innovative products to help them to deal with their daily impact of external influences such as stress, exhaustion, concentration and attention deficits. For more information, please visit: www.titan-commerce.com

About appPeople
Founded in 2011, appPeople GmbH develops and distributes mobile applications and medical devices. The innovative products enable the regular collection of relevant health parameters, helping to better assess treatment outcomes and improve users‘ quality of life. The dynamically growing company works with partners in Europe and Asia and is one of the most successful and creative names in its field. For more information, please visit: www.mehealthcheck.de

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

One Swiss model for the world – healthbank expands into Germany

healthbank Deutschland GmbH founded in Berlin – Karsten Stampa becomes CEO – Philosophy and values of the cooperative are transported

One Swiss model for the world - healthbank expands into Germany

Karsten Stampa

healthbank cooperative is expanding and has founded the subsidiary healthbank Deutschland GmbH in Berlin. CEO of the new company is Karsten Stampa, who contin-ues to act as COO/CFO of the parent company healthbank in Baar. „We are convinced that the model of a new and independent health data platform is not only a model for Switzerland, but for the whole world,“ explains Stampa.

The Swiss health data platform „healthbank“ revolutionizes the way personal health data is stored, used, exchanged and passed on for fair rewards. To this end, healthbank operates the world’s most advanced health data platform, which allows users to securely store health data and share it with doctors, hospitals and research institutions by means of authorization.

For Karsten Stampa, the move to Berlin is a logical step in health-bank’s expansion strategy. „We are convinced that our model of a neutral and independent health data platform is not only a model for Switzerland but will prevail all over the world.

The goal of healthbank in the near future is to offer the possibility of being able to use personal health data everywhere and at any time: „So not only at home, but also for example on vacation in the Serengeti or when one is on the road professionally“, explains Stampa. The data would be urgently needed, especially at remote locations in the event of a medical emergency, would help to understand people’s medical history quickly and easily and thus improve the quality of care, no matter where in the world it takes place“.

In terms of internationalization, the branch in Germany is the logical step for healthbank, explains Stampa. „The reasons are clear. In Germany, the domestic market with around 80 million inhabit-ants is of course very interesting. Much more exciting, however, is the fact that many international healthcare providers are based there alongside highly exciting start-ups with excellent, innovative approaches in the field of digital health. For example, we have entered into a cooperation with Thryve, a company that develops and sells software as a service in the field of mobile health applications,“ adds Stampa. In addition to the development of the national telematics structure or the development of the electronic health card, Stampa explains that many other developments can currently be observed in Germany. The first frontrunner projects of German insurers such as the Techniker Krankenkasse, the patient file of the AOK Nord-Ost or the health app Vivy were observed. „We are convinced that healthbank, as a bridge builder between the partially isolated ap-proaches, can make a major contribution to the control of health data among users in Germany.

This expansion will later be extended to other countries around the world. „This will enable us to export our future model. The healthbank cooperative is located in Switzerland and enables users to share their data with other partners in a secure and data protection-compliant manner. healthbank combines data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. For various reasons (including legislation), local operating companies will also have to be operated in the respective countries. „This will enable us to transport the philosophy and values of the Swiss cooperative to these countries and allow the healthbank ecosystem to grow rapidly worldwide,“ explains Stampa.
healthbank in Germany will soon start as a sales and operations company where customer relation-ships with German health service providers are to be established and project partners found. The core will be the announcement of the healthbank idea in Germany and the establishment of fur-ther customer relationships. „Through our cooperation with a globally active German management consultancy, we ensure a high degree of visibility in Germany“.

Stampa sees the implementation of the healthbank expansion strategy as one of his core tasks. „I have many discussions with potential customers and appearances at events,“ he explains. At the same time, the marketing strategy will be developed and implemented. „The search for investors and securing financing is always one of the most important tasks in such a project and is at the top of his list, explains the former management consultant in the areas of strategy and regulation. Stampa has therefore also planned a first funding round for the coming months in order to be able to build up the Marketing and Business Development department. „It may also be necessary to operate your own data platform in Germany so that an IT department can be added,“ explains Stampa.

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables people to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, researchers and organizations with large amounts of data to network with each other. This enables the value of health and medical data to be optimally exploited on this independent, global health platform. healthbank promotes innovations in the health care system, from prevention to cure, at a more reasonable price and of better quality – for the benefit of individuals and society. www.healthbank.coop

healthbank ist die weltweit erste bürgereigene, neutrale und unabhängige Gesundheitsdaten-Transaktionsplattform, die es Menschen ermöglicht ihre Daten auf sichere und datenschutzkonforme Art und Weise mit anderen Partnern zu teilen. healthbank verbindet Datenquellen aller Art aus dem gesamten Gesundheitsbereich und belohnt Teilnehmer, ihre Gesundheitsdaten für Forschungszwecke zu teilen. Mit Sitz in der Schweiz steht healthbank für schweizerische Neutralität, Vertrauen und Datenschutz und ermöglicht es den teilnehmenden Bürgern, Forschern und Organisationen mit grossen Datenmengen sich miteinander zu vernetzen. Damit kann der Wert von Gesundheits- und medizinischen Daten auf dieser unabhängigen, globalen Gesundheitsplattform optimal erschlossen werden. healthbank fördert Innovationen im Gesundheitswesen, von der Prävention bis zur Heilung, zu einem angemesseneren Preis und besserer Qualität – für das Wohl des Einzelnen und der Gesellschaft.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Medicine Wellness Health

2nd International Conference on Diabetes, Nutrition, Metabolism & Medicare

– November 05-06, 2018 | Philadelphia, USA

2nd International Conference on Diabetes, Nutrition, Metabolism & Medicare

Diabetes| Nutrition| Metabolism | Medicare- Join Hands to Eradicate the Diabetes
– November 05-06, 2018 | Philadelphia, USA
The significant progress Diabetes sector is hampered by patenting; Diabetic medicines will most likely always remain a niche market. Diabetes is one of the most challenging diseases throughout the world. The impact of diabetes on the individual quality of life and the general economy in Italy is substantial. There are a number of different types of diabetes drugs – with some having similar ways of acting. The 50+ diabetes drugs available in the world in the form of tablets or injection suspension and placed into different drug“s classes. A large number of innovations are therefore lost.
The Global Market for Diabetes Management accounted for 40 billion USD in 2010 and is anticipated to attain a market size of around 114 billion USD following a growth rate of 13.5% CAGR. The foremost products in this market consist of glucose meters, testing strips, lancets, continuous blood glucose meters, syringes, insulin pumps, insulin & its devices such as patches and anti-diabetic drugs. However, hypoglycaemic agent, test strips, and anti-diabetic drugs are the most revenue generating products.
While diabetes usually cannot be cured, drug manufacturers and biotech companies make glucose monitors, and drug products to assist to manage the condition. It’s calculable that entire market for diabetes products and related care is worth $92 billion in the U.S. The conventional therapeutic information is thought to be inside each one’s scope and does not require any review or preparing to practice it.
According to the (CMS) Centres for Medicare and Healthcare, 32nd of Medicare outlay is attributed to the diabetes population. Medicare has expanded medical coverage of monitoring devices, screening tests and visits, academic efforts, and preventive medical services for its diabetic enrolees. However, oral anti diabetic drugs and hypoglycaemic agents were excluded from reimbursement.
„2nd International Conference on Diabetes, Nutrition, Metabolism & Medicare“, going to be held during November 5-6, 2018 in Philadelphia, USA is going to be the biggest conference dedicated to Diabetes and its consequences day to day. It provides a premier technical forum for reporting and learning about the latest research and development, along with discussing new applications and technologies related to Diabetes, Nutrition, Metabolism & Medicare. Events include hot topics presentations from all over the world and professional networking with industries, leading working groups and panels. Diabetes Conference 2018 will be organized around the theme- „Join Hands to Eradicate the Diabetes“

Allied Academies is an established and reputed publisher which started publishing in the year 1994. Initially the focus of the group was to organize conferences and publish articles in the realm of Business and Management, with time the publisher expanded the subject scope and presently focusing on other subject areas.

Contact
Allied Academics
Karleen Gloria
85 Great Portland St pa
W1W 7LT Marylebone, London
Phone: +448000868979
E-Mail: diabetes@alliedscholars.net
Url: http://diabetesconference.alliedacademies.com/

Medicine Wellness Health

Dr. Hüseyin Sahinbas: New President of German Hyperthermia Society

Shanghai 2018 – Successful DGHT-eV expansion in China

Dr. Hüseyin Sahinbas: New President of German Hyperthermia Society

Dr. Sahibas present DGHT-eV

With Dr. Hüseyin Sahinbas, whose areas of specialty include hyperthermia, the German Hyperthermia Society, or DGHT-eV for short ( www.dght-ev.de), has elected a new president with particularly ambitious goals. One of his first actions in office involved setting up an academic exchange with colleagues in China and entering into a cooperation agreement with Shanghai“s Shulan Hospital. Both parties expect a creative and intensive clinical and scientific exchange in this context, in order to „further expand the quality and application of hyperthermia,“ according to Dr. Quing Xu, Director of the Tongji University Cancer Center. In addition to further scientific studies, this work will include defining and implementing guidelines for performing hyperthermia treatments with regard to individual entities. The objective of this step is to further establish the relevance of hyperthermia in conventional school medicine and to boost its acceptance. „We not only want to expand our international contacts, but also want to foster the cooperation of national associations,“ said Dr. Sahinbas, who outlined his goals as DGHT-eV President as follows:

– Build bridges between all associations dedicated to complementary (oncological) and conventional fields
– Build bridges between decision-makers in politics and medicine
– Build bridges between scientific research and colleagues working „in the trenches“
– Build bridges between doctors and affected patients seeking help
– Build bridges between science, patients and the media

„Hyperthermia is already supported by detailed studies in many areas and now has to make the leap to becoming accepted by insurance systems,“ says Dr. Sahinbas, adding, „This will be one of my core tasks as President. I will largely act as a link between many associations and colleagues, I see myself as a bridge builder for politics, science, but also for commercial institutions in medicine and insurance.“ True to his motto „It takes a vision to have a current plan,“ DGHT-eV will reposition itself within this framework to provide more active support for colleagues and to convince other physicians of the benefits of this therapy form. In order to achieve this in the near future, intensive talks are currently underway, for example at the Berlin Charite Hospital, to create a „hyperthermia specialist“ training course. „Clear guidelines and specialist training will make hyperthermia significantly more attractive for junior colleagues, and we hope to generate broad interest among young doctors. I particularly look forward to the task of communicating knowledge and experience in the treatment of cancer patients.
That makes my position as president of DGHT-eV very gratifying,“ says Dr. Sahinbas, whose long-term objectives include establishing an independent professorship for hyperthermia.

Dr. Hüseyin Sahinbas – President DGHT-eV

Bei Krebsleiden und chronischen Krankheiten ist die Hyperthermie mittlerweile mehr als nur ein Hoffnungsschimmer zur Prognoseverbesserung. Denn Hyperthermie kann Leben retten, verlängern und erheblich verbessern.

Das ist das Ziel der DGHT-eV

Company-Contact
DGHT-eV
Hüseyin Sahinbas
Gutenbergstr. 8
26135 Oldenburg
Phone: +49 441 – 936 54 58 – 6
E-Mail: info@dght-ev.de
Url: http://www.dght-ev.de

Press
DGHT-e.V.
Hüseyin Sahinbas
Gutenbergstr. 8
26135 Oldenburg
Phone: 0441 – 936 54 58 – 6
E-Mail: info@dght-ev.de
Url: https://www.dght-ev.de/home

Medicine Wellness Health

Best of both worlds in health science Advancience and healthbank

The data science company together with the GDPR compliant health data platform healthbank. A combination of two innovative ideas, both concerned about the secure storage of health data and both the community first.

Best of both worlds in health science Advancience and healthbank

With the connection of healthbank from Baar and Advancience from Allschwil the need of gathering anonymous data to develop instruments for psychometric profiling and storing health data safe on the healthbank platform are covered.

„As ongoing data collection is a fundamental pillar of our research strategy to continuously evolve and improve our product portfolio, we put data and privacy protection of our user community first“ says Founder and CEO of Advancience, Christian Vogler. The basic ideas is to develop a software to e.g. early detect diseases through pychometric profiling.

This cooperation underlines once again that healthbank is the perfect platform for start-ups in e-health when they need anonymous data and do not have the possibilities or the means for data storage that meets the highest security standards themselves . healthbank provides the perfect solution. In a completely new architectural approach, security was raised to the highest level through end-to-end encryption and the range of functions for users is expanded.

The key to next generation medicine/psychology is collecting large datasets. Yet, while doing this, it is of utmost importance to give control and profit back to the data generators: Us all. This is what excites me most about partnering with healthbank: It provides us with a unique opportunity to achieve all three goals, says Christian Vogler.

The healthbank platform is optimally designed to integrate partners and applications from the health sector quickly, efficiently and highly securely. For Advancience it means that this cooperation allows them to provide individual mental fitness tracking without collecting any personally identifying data.

About Advancience
Advancience AG (in formation) is a data science company that develops and applies game-based and neuroscience guided mental fitness tracking and psychometric profiling. We make full use of the potential of digitalization to provide highly scalable software solutions for psychological assessment. By reinventing and innovating the psychological toolkit, we strive to bring the new possibilities of modern information technology to applied psychology. Our instruments can be employed wherever psychological profiles need to be relied on to better accomplish the task at hand: From applica-tions in human resources to healthcare.
www.advancience.io

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables peo-ple to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, research-ers and organisations with large amounts of data to network with each other. Thus, the value of health and medical data can be optimally tapped on this independent, global health platform. healthbank promotes innovations in health care, from prevention to cure, at a more reasonable price and of better quality, for the benefit of individuals and society.
www.healthbank.coop

Press contact healthbank
healthbank innovation AG
Pauline Geniets
Blegistrasse 17a, CH-6340 Baar
Tel. +41 (0) 41 552 24 00
press@healthbank.coop

Press contact Advancience
Advancience AG (in formation)
Dr. Christian Vogler, CEO
Gewerbestrasse 24, CH-4123 Allschwil
Tel. +41 78 924 33 26
christian.vogler@advancience.ch

healthbank ist die weltweit erste bürgereigene, neutrale und unabhängige Gesundheitsdaten-Transaktionsplattform, die es Menschen ermöglicht ihre Daten auf sichere und datenschutzkonforme Art und Weise mit anderen Partnern zu teilen. healthbank verbindet Datenquellen aller Art aus dem gesamten Gesundheitsbereich und belohnt Teilnehmer, ihre Gesundheitsdaten für Forschungszwecke zu teilen. Mit Sitz in der Schweiz steht healthbank für schweizerische Neutralität, Vertrauen und Datenschutz und ermöglicht es den teilnehmenden Bürgern, Forschern und Organisationen mit grossen Datenmengen sich miteinander zu vernetzen. Damit kann der Wert von Gesundheits- und medizinischen Daten auf dieser unabhängigen, globalen Gesundheitsplattform optimal erschlossen werden. healthbank fördert Innovationen im Gesundheitswesen, von der Prävention bis zur Heilung, zu einem angemesseneren Preis und besserer Qualität – für das Wohl des Einzelnen und der Gesellschaft.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Medicine Wellness Health

biolitec®: Risk patients benefit from laser channel technology for BPH

Laser channel technology with biolitec® lasers successfully applied to treat in high-risk patients in Japan – Gentle, safe, fast, few side effects – Excellent hemostasis with fast, residue-free ablation

biolitec®: Risk patients benefit from laser channel technology for BPH

Prostate treatment with biolitec® fiber TWISTER (Source: biolitec biomedical technology GmbH)

Jena, July 11th, 2018 – The minimally invasive laser treatment LIFE (Laser Induced Flow Enhancement) by medical laser pioneer biolitec biomedical technology GmbH with its channel technology is particularly well suited for the treatment of benign prostate hyperplasia in high-risk patients. This is due to the optimal wavelength of the biolitec® laser (980 nm and 1470 nm) and to the special properties of the TWISTER and XCAVATOR® laser fibers, also specially developed by biolitec®. These are currently one of the gentlest, safest and fastest laser treatments with the fewest side effects and are therefore particularly suitable for high-risk patients. The channel technology offers the possibility of removing the tissue of the urinary tract of the prostate from the inside in a targeted manner without leaving any residue.

The biolitec® laser was one of the first lasers on the market with a wavelength of 980 nm and 1470 nm. This wavelength offers the highest absorption in water and hemoglobin and consequently enables excellent hemostasis. Less bleeding during the procedure improves visibility in the surgical area.
The TWISTER and XCAVATOR® laser fibers stand out due to their enlarged contact area and a special coating on the fiber tip, which enables faster ablation and more precise fiber guidance. The biolitec® fibers also work in contact mode. This significantly reduces the coagulation zone (smaller than 1 mm) and the bladder and surrounding tissue are protected, incontinence and sexual dysfunction are usually avoided.

The LIFE method has proven itself among other things in the treatment of high-risk patients. Urologists at Harasanshin Hospital Fukuoka in Japan have helped to develop this special channel technique and have operated on 26 patients who either suffer from diabetes and/or need to take anticoagulants. In addition, all patients had large prostates (on average over 100 to 200 g).

Doctors at Harasanshin Hospital Fukuoka were able to operate much faster than with conventional procedures – one hour on average – and to reach a large cavity without having to remove the tissue completely. The side effects, such as swelling, dysuria or retention, which are particularly common in large glands, did not occur. In addition, the treating physicians were enthusiastic about the good manageability and quality of the biolitec® laser system.

Further information on biolitec® lasers and special fibers as well as the possibilities of participating in workshops for doctors can be found on the website www.biolitec.com. Interested patients can find out more about doctors who use the LIFE method at www.info-prostate.com.

About biolitec
biolitec® is one of the world“s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world“s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®“s field of business. More information available at www.biolitec.com

Contact
biolitec biomedical technology GmbH
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com

Medicine Wellness Health

Best Hair Transplant in Turkey; Clinics and Offers

Best Hair Transplant in Turkey; Clinics and Offers

Over the last few years Turkey has became the first destination when it comes to health tourism. The best hair transplant in turkey offers all what a patient can ask for ; from the post surgery follow-up to the final guaranteed result. Hair transplant and plastic surgery are a flourishing filed in Turkey; clinics and hospitals are competing each other to offer the best services packages and to fulfill the needs and demands of their international patients , which qualifies them to be; not only the best hair transplant clinic in turkey but also in the world . If you are wondering how to find the best hair implants in turkey and how to make the best choice and choose the right clinic or surgeon this article is going to answer to the latter questions.

Best hair clinic in turkey is a little bit hard to find ; as we can’t name one clinic or hospital and refer to it as the ultimate best choice . Going through several clinics‘ and surgeons‘ results old patients‘ feedback and price offers can be the determinant point to either make a step forward and engage with the clinic or move on and look for the best hair transplant center in turkey . Sometimes it can be surprising when it comes to the difference in prices between clinics and hospitals ; for the reason of services including with the surgery and the used technique . Best hair transplant in turkey istanbul depends on the reputation of the surgeon; his experience and patients‘ satisfaction.

Best hair transplant in turkey istanbul offers a variety of methods ; Nowadays, hair transplantation can be reduced to two main techniques: FUE and DHI. Which method is best for me and how many grafts do i need ; is one session enough to cover all my baldness ; are the most frequently asked questions before engaging to have the surgery done , most of the time in the process of searching for the best place for hair transplant in turkey on the internet or online medical platforms can not answer to all your questions and inquires and even sometimes it can be misleading. For this reason, the best way to get an accurate estimate of the cost and best technique for you would be to set up a consultation with a hair transplant specialist ; best hair transplant doctors in turkey who can evaluate your particular situation. It is difficult to generalize an average cost of hair transplant procedures as it depends on the specificity of each patient’s hair loss circumstances.

Eurozen Hair exist a great team including 44 persons ,13 asistan nurses,12 persons who are experts at plastic surgeon and 19 experts proffessional hair planters.
We realize your hairtransplantation by expert surgens and team proffessional.Eurozen Hair Transplant is the company which has a legal accountability and is rigorous about the hospital and health personnel.
We serve for 16 years with our equipmant which has latest technology, equipped operating rooms,academic staff and special doctors in enviroment of hospital full-fledged.
Eurozen has mission and vision providing Turkey as one of the first places in the world about hair tranplantation, sharing many contents of information and technical, following the developments in Canada,U.S.A, and Europe about hair transplantation.

Company-Contact
EuroZen Hair Transplant Center
Ismail Zengin
Fulya Life Residence Merkez Mah. Prof. Dr. Bülent Tercan Sok. No:16 16
34394 istanbul
Phone: +90(542) 231 2810
E-Mail: info@eurozenhairtransplant.com
Url: https://en.eurozenhairtransplant.com

Press
EuroZen Hair Transplant Center
ahmet taş
Fulya Life Residence Merkez Mah. Prof. Dr. Bülent Tercan Sok. No:16 16
34394 istanbul
Phone: +90(542) 231 2810
E-Mail: info@eurozenhairtransplant.com
Url: https://en.eurozenhairtransplant.com

Medicine Wellness Health

healthbank enters into partnership with Sanovation

Health database platform healthbank gains over 200,000 additional users with pain diary apps from Sanovation

healthbank enters into partnership with Sanovation

Sanovation

Merger of two Swiss start-ups in the digital health sector. With the cooperation of the health data platforms healthbank from Baar and Sanovation AG from Zug, the users of the two innovative start-ups will receive a multitude of new possibilities with their health data.

Sanovation brings over 200,000 registered users of its pain diary apps „CatchMyPain“ and „Pain-Companion“ into the partnership. healthbank in return
offers users a highly secure storage for health data under their full control and an innovative data exchange platform. As a central agency for individuals, health service providers and researchers, healthbank increases the quality of care and lowers global health costs.

„The partnership with Sanovation is a further step towards a successful future for healthbank,“ explains Reto Schegg, CEO of healthbank. „With this partnership, users of the award-winning ‚CatchMyPain‘ and ‚Pain Companion‘ apps will be absolutely certain that their health data is not only safe and in full control. Users can also share data with recipients of their choice – participate in research projects worldwide and make their data available to research institutions. You will even be rewarded.“

One in five adults suffers from chronic pain
Today, according to Sanovation, one in five adults suffers from chronic pain. The aim of the intelli-gent pain diary „CatchMyPain“ is to enable a detailed, ongoing recording of pain samples. With „Pain Companion“, users can find similar patients by comparing the pain diaries, who can exchange information directly with each other or in a community. Thanks to the two Sanovation Apps, patients and their doctors and therapists receive a meaningful communication tool, especially through long-term recording.

The analysis of a large number of pain diaries, if users allow it, will lead to new findings in pain medicine. Reto Schegg adds: „The knowledge about chronic pain is currently scattered on many paper archives of doctors, therapists and hospitals. This makes it practically impossible to systematically compare and analyze pain cases. The cooperation between Sanovation and healthbank can signifi-cantly improve this problem. For Sanovation CEO and Chairman of the Board Roman Haag, this could improve the quality of life of millions of patients worldwide. In addition, administrative processes and treatments become more efficient and thus more cost-effective. „The cooperation with healthbank will improve the situation of chronic pain patients in the long term. On the other hand, we see great potential in the integration of additional data sources such as medication or fitness data, which is only made possible by the cooperation with healthbank. Haag explains. With the new basic data protection regulation of the European Union (GDPR), the cooperation makes an important contribution to the data protection of users. According to Reto Schegg, „CatchMyPain“ and „Pain Companion“ are just two of many applications that will be running on the healthbank platform in the future and with which users can manage their health data, explains Reto Schegg.

About Sanovation AG
The pain diary CatchMyPain is developed and maintained by the Swiss start-up Sanovation AG in Zug. Sanovation was founded in November 2011 and since then works exclusively on CatchMyPain. The idea for CatchMyPain came from the pain story of a co-founder. The application is primarily aimed at people with chronic pain who feel similar pain over a longer period of time. The vision of Sanovation AG is to help individual users on the basis of all collected user data by com-paring symptoms and making recommendations.

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables peo-ple to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, research-ers and organisations with large amounts of data to network with each other. Thus, the value of health and medical data can be optimally tapped on this independent, global health platform. healthbank promotes innovations in health care, from prevention to cure, at a more reasonable price and of better quality, for the benefit of individuals and society.
www.healthbank.coop

Press contact healthbank

healthbank innovation AG
Karsten Stampa CFO/COO
Blegistrasse 17a, CH-6340 Baar
Tel. +41 (0) 41 552 24 00
press@healthbank.coop

Press contact Sanovation

Sanovation AG
Weinbergstrasse 48, CH-6300 Zug
Roman Haag, VRP
contact@sanovation.com

healthbank ist die weltweit erste bürgereigene, neutrale und unabhängige Gesundheitsdaten-Transaktionsplattform, die es Menschen ermöglicht ihre Daten auf sichere und datenschutzkonforme Art und Weise mit anderen Partnern zu teilen. healthbank verbindet Datenquellen aller Art aus dem gesamten Gesundheitsbereich und belohnt Teilnehmer, ihre Gesund-heitsdaten für Forschungszwecke zu teilen. Mit Sitz in der Schweiz steht healthbank für schweizerische Neutralität, Ver-trauen und Datenschutz und ermöglicht es den teilnehmenden Bürgern, Forschern und Organisationen mit großen Daten-mengen sich miteinander zu vernetzen. Damit kann der Wert von Gesundheits- und medizinischen Daten auf dieser unab-hängigen, globalen Gesundheitsplattform optimal erschlossen werden. healthbank fördert Innovationen im Gesundheits-wesen, von der Prävention bis zur Heilung, zu einem angemesseneren Preis und besserer Qualität – für das Wohl des Ein-zelnen und der Gesellschaft.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Medicine Wellness Health

Maisense Presents Smart AI Cardiovascular Care Solution

Maisense Presents Smart AI Cardiovascular Care Solution

Freescan, the personal cardiovascular monitoring device (Source: © Maisense)

First all-in-1 Personal Cardiovascular Monitor and AI-based Stroke Prevention System to enable early detection of key factors indicating stroke risk

Hsinchu, Taiwan May 28th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention. The company“s corporate mission is to assist users with early detection of atrial fibrillation, and to support physicians in the efficient treatment and better cardiovascular care for their patients. Unlike other cardiovascular care products, which need multiple devices to measure ECG/EKG and blood pressure separately, Maisense Freescan in combination with the myFreescan App delivers an all-in-1 solution for early atrial fibrillation detection, arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device.

The Maisense Healthy Heart Hub (HHH) is a smart solution for cardiovascular care which consists of 3 components:

1. Freescan – the personal cardiovascular monitoring device for the patients and health conscious users. The device senses the lead 1 ECG and radial artery pulse by using 3 electrodes (1 as RA, 1 as LA, 1 as RL) combined with 1 pressure sensor. With the aforementioned bio-signals, Freescan can register parameters such as pulse transmission time (PTT), and calculates systole (SYS) and diastole (DIA) blood pressure respectively according to a formula. The devices can also calculate the heart rate (HR) and indicates irregular heartbeat. With its build-in Bluetooth technology, Freescan uploads each measurement to the Mobile App, and combines it with Maisense artificial intelligence (AI) to provide additional conclusions. The device has received an EU CE medical certification.

2. myFreescan – the Mobile App for patients or health conscious users to keep track of their personal health trends and to screen AFib/Arrhythmia. In addition, the pulse waveform and ECG/EKG waveform captured by Freescan provide the artery pulse wave velocity which is the indicator for artery stiffness and alerts the user to seek professional medical advice.

3. The Patient Care System – the platform used by doctors and professional physicians to monitor a patient“s vital parameters. Through the system personalized advices can be given instantly to guide patients. A detailed health report can be generated by the doctors via the system to support the patients for short-term/long-term heart health monitoring.
Freescan could proof a highly exact performance compared with Holter monitor systems in clinical field tests. In May 2018, Maisense finished the clinical research on AFib detection in the Chang-Gung Memorial Hospital, Keelung, Taiwan. The clinical results demonstrate the feasibility of using Freescan in detecting AFib as the preliminary screening results with over 95% sensitivity and over 99% specificity. The clinical results are under submission to the American Heart Association (AHA) 2018.

Maisense will present the solution at the ESH (European Society of Hypertension) conference in Barcelona from June 8th-11th in hall 8, booth 22, In addition to product demos for Freescan, myFreescan and the Patient Care System, the Maisense experts are available to discuss atrial fibrillation detection and the latest results of clinical studies.

Freescan is now available in Germany at Mindtech ( https://www.mindtecstore.com/Maisense_1). Maisense is looking for distributors in European Union.

Maisense is proud to be a member of the Global Research & Industry Alliance (GLORIA-Semicon) which focuses on future-oriented technology and builds a cooperation platform between universities and the industry. The organization stimulates innovation and introduces Taiwan startup companies to the global market. GLORIA will also exhibit alongside Maisense at ESH – booth 22.

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

www.biolitec.com: New website presents modern medical laser therapies

biolitec® has launched a new website – Functional modern design – Worldwide leading developer and manufacturer of minimally invasive laser therapies – Successful research and development in areas such as phlebology and proctology – 10 years ELVeS®

www.biolitec.com: New website presents modern medical laser therapies

biolitec®_Homepage_en (Source: @biolitec biomedical technology gmbh)

Jena, May 22, 2018 – The developer and manufacturer of medical laser systems for minimally-invasive therapies, biolitec biomedical technology GmbH, has unveiled its new online presence. A modern layout now stands for an adapted innovative website functionality and a better overview of the company’s versatile product and application areas: Thanks to the new tile design, the entire website is structured in a way that the extensive range of medical applications and laser systems of biolitec® can be recognized at first glance.

This principle of fast recognition can be found both in the subject area for doctors and for patients. This, for instance, gives doctors an immediate overview of all biolitec® lasers. For example, if the visitor clicks on the „Dual 100“ tile, he can, due to the simple depiction, see all the therapeutic areas in which this laser can be used.

The same applies to patients: The respective therapy subpages under the menu item „patients“ lead directly to the patient websites adapted to the special needs of patients, such as www.info-varicose-vein.com, which can also be accessed as independent websites.

Founded more than 30 years ago, biolitec® has become one of the world’s leading companies in the field of minimally invasive laser therapies – due to continuous research and development of its products. Thanks to subsidiaries, including in South America and Asia, its innovative laser systems and methods are available for a wide range of applications for gentle and low-intensity treatment options all around the globe. biolitec® lasers are often innovative alternatives to conventional treatment methods in phlebology, proctology, thoracic surgery, urology, gynecology, ENT and orthopedics.

For 10 years now, the unique ELVeS® Radial® 2-ring laser fiber of biolitec®, with its efficient and simple technology, has been convincing in the treatment of varicose veins.

As a result of intensive research, biolitec® has always been able to offer the most modern possibilities in minimally invasive laser medicine. The new LEONARDO® laser family by biolitec® includes the only laser systems available on the market in which two wavelengths can be adjusted and used independently and continuously during the treatment. The universal applicability of the lasers in various fields of application is unique.

Further information on all products and applications of the laser therapies by biolitec® is available directly on the new website www.biolitec.com.

About biolitec
biolitec® is one of the world“s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world“s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®“s field of business. More information available at www.biolitec.com

Contact
biolitec biomedical technology GmbH
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com